DE231056C - - Google Patents

Info

Publication number
DE231056C
DE231056C DENDAT231056D DE231056DA DE231056C DE 231056 C DE231056 C DE 231056C DE NDAT231056 D DENDAT231056 D DE NDAT231056D DE 231056D A DE231056D A DE 231056DA DE 231056 C DE231056 C DE 231056C
Authority
DE
Germany
Prior art keywords
bacilli
serum
tuberculosis
specific
tuberculin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT231056D
Other languages
German (de)
English (en)
Publication of DE231056C publication Critical patent/DE231056C/de
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DENDAT231056D Active DE231056C (enExample)

Publications (1)

Publication Number Publication Date
DE231056C true DE231056C (enExample)

Family

ID=491209

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT231056D Active DE231056C (enExample)

Country Status (1)

Country Link
DE (1) DE231056C (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1966436A1 (de) * 1968-05-28 1972-12-07 Merieux Inst Vaccinen und Verfahren zu ihrer Herstellung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1966436A1 (de) * 1968-05-28 1972-12-07 Merieux Inst Vaccinen und Verfahren zu ihrer Herstellung

Similar Documents

Publication Publication Date Title
DE69034100T2 (de) Verktorvermittelte genominsertion und expression von dna in bcg
Osborne et al. Patterns of amino acid release from nerve‐endings isolated from spinal cord and medulla
Minton Jr Paraspecific protection by elapid and sea snake antivenins
WO2012123590A1 (de) Tcralpha/beta-depletierte zellpräparationen
DE231056C (enExample)
EP1124575B1 (de) Verfahren zur herstellung eines antiviralen mittels
Granit Reflexes to stretch and contraction of antagonists around ankle joint
D'Antonio et al. Malaria resistance: artificial induction with a partially purified plasmodial fraction
Oftung et al. A novel mycobacterial antigen relevant to cellular immunity belongs to a family of secreted lipoproteins
Fukushima et al. Extraction and purification of a substance with luteinizing hormone releasing activity from the leaves of Avena sativa
DE69712907T2 (de) Immunogene tlp-zusammensetzung
Gamble Comparison of immune effects in mice immunized with Trichinella spiralis adult and larval antigens
Pusztai Studies on the extraction of nitrogenous and phosphorus-containing materials from the seeds of kidney beans (Phaseolus vulgaris)
Bhaskar et al. Isolation, purification and immunological characterization of novel low molecular weight protein antigen CFP 6 from culture filtrate of M. tuberculosis
Al-Safadi Additions to the scorpion fauna of Yemen
Woodard et al. Immunogenic properties of soluble antigens or whole cells of Brucella abortus strain 45/20 associated with immunoadjuvants. I. Soluble antigens
DE1617605C3 (de) Verfahren zum Herstellen eines Pertussis-Antigens
Englert et al. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund’s adjuvant
DE69420016T2 (de) Verwendung eines TMA-Komplexes und/oder eines Fragmentes dieses TMA Komplexes für die Herstellung eines Arzneimittels für die Behandlung und/oder die Vorbeugung von Krebs
DE1818054C2 (de) Verfahren zur Gewinnung von cytobiotischen Globulinen
Levy et al. Enrichment of the murine Natural Killer (NK) and mitogen induced cellular cytotoxicity (MICC) cells using preparative free-flow high voltage electrophoresis
DE231055C (enExample)
Harris et al. Partial purification of bovine intestinal alkaline phosphatase.
US3386882A (en) Purified vaccine from brain tissue
Denis et al. Culture filtrate specific H-2b restricted CD8+ T cells activated in vivo by Mycobacterium tuberculosis or bovis BCG recognize a restricted number of immunodominant peptides